Prafulla C. Gokhale

机构：Harvard University, Dana-Farber Cancer Institute, Center for Cancer Research, Io Therapeutics (United States) · ORCID：0000-0002-1974-5921

发表论文 552 篇 · 总被引 10456 次 · h-index 40

代表论文

PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer (2026 · Journal of Clinical Investigation)
Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models (2026 · Journal of Clinical Investigation)
Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemia (2026 · Haematologica)
Figure S1 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors (2026)
Figure S7 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors (2026)
Figure S8 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors (2026)